Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 11 » Issue 1
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® (ENERGITO® study)
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
29,735 | Dovepress* | 23,186+ | 2,848 | 26,034 | |
PubMed Central* | 6,549 | 2,828 | 9,377 | ||
Totals | 29,735 | 5,676 | 35,411 | ||
*Since 3 February 2016 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
8 | 0 | 0 | 0 | 2 | 6 |
View citations on PubMed Central and Google Scholar